Clinical Trials on Lumbar Degenerative Disc Disease in Japan

Total 108 results

DiscGenics, Inc.

Completed

Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Disc Degeneration

Degenerative Disc Disease

Japan
Seikagaku Corporation

Completed

SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation

Lumbar Vertebra Hernia

Japan
Kyorin University

Completed

Vitrectomy for Optic Disc Pit Maculopathy

Optic Disc Pit Maculopathy

Japan
Tokyo Medical and Dental University

Completed

Randomized Clinical Trial of Treatment for Temporomandibular Joint (TMJ) Disc Displacement

Temporomandibular Disorders | Herniated Disk

Japan
Mie University

Unknown

Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

Exudative Age-related Macular Degeneration

Japan
Nagoya City University
Novartis

Completed

Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.

Neovascular Age-related Macular Degeneration

Japan
Kyowa Kirin Co., Ltd.

Terminated

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

Healthy Volunteers | Wet Age-related Macular Degeneration

Japan
Kumamoto University

Completed

Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration

Age-related Macular Degeneration

Japan
Osaka University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Age Related Macular Degeneration | Neovascular Maculopathy

Japan
Nihon University

Completed

Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration

Age-related Macular Degeneration

Japan
Bayer
Regeneron Pharmaceuticals

Completed

EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan

Macular Degeneration

Japan
Bayer
Regeneron Pharmaceuticals

Completed

Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan

Wet Macular Degeneration

Japan
Kyorin University

Completed

Surgical Outcome of Vitrectomy for Myopic Traction Maculopathy in Highly Myopic Eyes

Surgery | High Myopia | Maculopathy

Japan
Novartis

Completed

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)

Japan
Santen Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)

Diabetic Macular Edema

Japan
Bayer

Completed

Special Drug Use Investigation of EYLEA for Diabetic Macular Edema

Macular Edema

Japan
Bayer
Regeneron Pharmaceuticals

Completed

EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan

Macular Degeneration

Japan
Kyorin University

Completed

Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction Maculopathy

Myopic Traction Maculopathy

Japan
Kagawa University
Novartis Pharmaceuticals

Completed

Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema

Diabetic Macular Edema

Japan
Stryker Japan K.K.

Completed

Navigation With X3 vs Non-Navigation With X3 Study

Degenerative Joint Disease

Japan
Ophthalmic PDT Study Group

Completed

PDT Study for Exudative AMD With PCV

Age Related Macular Degeneration

Japan
Bayer

Completed

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA) (AURA)

Ophthalmology, Macular Degeneration

Japan, France, Germany, Australia, Italy, United Kingdom, Venezuela, Ireland, Netherlands, Canada
Kyoto University, Graduate School of Medicine
Novartis

Unknown

Ranibizumab Treatment for Retinal Vein Occlusion

Macular Edema Due to BRVO/CRVO

Japan
Allergan

Completed

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD (PINE)

Macular Degeneration

Japan
Tokyo Medical University

Unknown

Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion

Central Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein Occlusion

Japan
Mie University

Unknown

Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO (CRVO)

Central Retinal Vein Occlusion

Japan
Alvotech Swiss AG

Active, not recruiting

Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE) (ALVOEYE)

Neovascular (Wet) AMD

Slovakia, Czechia, Georgia, Japan, Latvia
Showa University

Completed

The Effect of a Blue Light Filtering IOL

to Compare the Effect of Two Types of IOLs | on the Incidence of Cystoid Macular Edema | After Cataract Surgery

Japan
Nagoya City University
Novartis

Completed

Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Japan
Kyorin University

Completed

Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy

Myopic Traction Maculopathy | Macular Hole Retinal Detachment

Japan
Zimmer Biomet

Completed

A Study on M2a Magnum Total Hip Arthroplasty

Avascular Necrosis | Degenerative Joint Disease

Japan
Assiut University

Unknown

PIC and Its Role in Progression of Pathological Myopia

Punctate Inner Choroidopathy

Japan
Kyowa Kirin Co., Ltd.

Completed

A Clinical Study of KW-3357 in Patients With DIC (3357-005)

Disseminated Intravascular Coagulation (DIC)

Japan
Janssen Pharmaceutical K.K.

Withdrawn

Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)

Macular Degeneration | Geographic Atrophy | Visual Acuity

Japan
Kyowa Kirin Co., Ltd.

Terminated

A Phase 3 Clinical Study of KW-3357 in Patients With DIC (3357-006)

Disseminated Intravascular Coagulation (DIC)

Japan
Novartis Pharmaceuticals

Active, not recruiting

Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy

Biallelic RPE65 Mutation-associated Retinal Dystrophy

Japan
Stryker Japan K.K.

Unknown

Large Head X3 Study

Degenerative Joint Disease

Japan
Santen Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)

Macular Edema Following Branch Retinal Vein Occlusion

Japan, Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

An Open-label Study of KW-3357 (3357-004)

Disseminated Intravascular Coagulation (DIC)

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema

Diabetic Macular Edema

Japan
Janssen Pharmaceutical K.K.

Completed

An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa

X-Linked Retinitis Pigmentosa

Japan
Bayer

Recruiting

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

Visual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)

Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
Kyorin University

Completed

Macular Detachment Associated With Intrachoroidal Cavitation

Macular Retinoschisis | Macular Detachment | Intrachoroidal Cavitation

Japan
Astellas Pharma Inc

Completed

Development of Visual Function Evaluation Method (2)

Retinitis Pigmentosa

Japan
Astellas Pharma Inc

Completed

Development of Visual Function Evaluation Method

Retinitis Pigmentosa

Japan
Janssen Pharmaceutical K.K.

Recruiting

A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa

X-Linked Retinitis Pigmentosa

Japan
Aesculap AG

Completed

Non-Interventional, Multicenter Bicontact® E PMCF Study

Rheumatoid Arthritis | Femoral Neck Fractures | Femoral Head Necrosis | Degenerative Osteoarthritis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Allergan

Completed

A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration

Macular Degeneration

Japan
Bayer
Regeneron Pharmaceuticals

Completed

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration (ALTAIR)

Wet Macular Degeneration

Japan

Clinical Trials on Lumbar Degenerative Disc Disease in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations